Our COO Stijn Heessen will be meeting new and old partners first at the BioTrinity and then at the Anglonordic meeting in London today and tomorrow. Please reach out if you are at these events!
Alder Therapeutics
Bioteknik
Solna, Stockholm County 1 373 följare
Shaping the future of regenerative medicine
Om oss
At Alder Therapeutics, we are on a bold mission to cure the incurable by bringing pluripotent stem cell-developed therapies to the benefit of patients. We are developing two promising allogeneic stem cell therapies, both with pre-clinical proof of concept data. Our lead program is a retinal cell therapy to treat Retinitis Pigmentosa, with a second program to tackle heart failure. Our industry-renowned team has decades of expertise in the scientific, technical and commercial aspects of bringing game-changing allogeneic cell therapies to market. Our focus is on de-risking cell therapy development by keeping the commercial product in mind from the start.
- Webbplats
-
www.aldertx.com
Extern länk för Alder Therapeutics
- Bransch
- Bioteknik
- Företagsstorlek
- 2–10 anställda
- Huvudkontor
- Solna, Stockholm County
- Typ
- Privatägt företag
- Grundat
- 2022
Adresser
-
Primär
Få vägbeskrivning
Nanna Svartz väg 4
Solna, Stockholm County 171 65, SE
Anställda på Alder Therapeutics
Uppdateringar
-
It will be an exciting Advanced Therapies 2025 conference next week! Our COO Stijn Heessen will be joining two panels and will also give his perspective on how startups should think about regulatory strategy.
-
Alder co-founders Stijn Heessen and Kristian Tryggvason share their viewpoint on investing in cell therapy companies in this recent article in Cell & Gene Therapy Insights. Investors would benefit from asking more questions about CMC when evaluating cell therapy companies is the key take-away. https://lnkd.in/gvNcPadM
-
Our CEO, Kristian Tryggvason will be speaking at the SACHS 18th Annual European Life Science CEO Forum in Zurich next week on the 26th and 27th of February. Don’t miss out on the opportunity to hear or meet him. #Sachs_ELSF #regenerativemedicine #biotech
-
-
Stijn Heessen presented Alder and our aim to shape the future of regenerative medicine at the Dutch Life Science pitch contest and won it! I guess we are then Dutch Champions!
Today is a day for winners 🏆 ! We congratulate Sniper Therapeutics, the winner of the Venture Challenge Fall 2024. We celebrate the winner of the Investor Forum 2024 Stijn Heessen, Alder Therapeutics. We thank our speakers, Suzanne Spliethoff and our partners and exhibitors for making today an exciting event where the Dutch life science industry connected, met up again and shared lessons and experience here at CORPUS Congress Centre . And special thanks to our attendees, who help make this another great event for the Dutch Life Sciences. We look forward to seeing you again in 2025 on December 11! If you wish to be notified first when the early-bird tickets become available, sign up for our news update: https://lnkd.in/ek5k_T-c
-
-
𝗛𝗮𝘃𝗲 𝘆𝗼𝘂 𝗿𝗲𝗴𝗶𝘀𝘁𝗲𝗿𝗲𝗱 to be part of the conversation on the turning point in treating blindness yet? Join Dr. Kristian Tryggvason and Dr. Stijn Heessen as they form part of an expert panel in the webinar "Treating Blindness with Stem Cell Therapies," hosted by BioLamina at 3pm GMT. 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗻𝗼𝘄 to: • Discover ground-breaking advancements in PSC-driven therapies for eye diseases • Explore the future potential of stem cell technologies in vision care • Gain valuable industry insights from key opinion leaders 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗵𝗲𝗿𝗲: https://lnkd.in/eWVe3vd4 #Biotechnology #CellTherapy #RegenerativeMedicine
-
𝗗𝗶𝗱 𝘆𝗼𝘂 𝗸𝗻𝗼𝘄 that vision loss and ocular degeneration in the USA contribute to an annual economic burden of $139 billion? While gene therapies offer promising treatments for these often untreatable conditions, access remains limited for many patients. We're excited to announce that 𝗗𝗿. Kristian Tryggvason 𝗮𝗻𝗱 𝗗𝗿. Stijn Heessen 𝗳𝗿𝗼𝗺 Alder Therapeutics 𝘄𝗶𝗹𝗹 𝗯𝗲 𝗷𝗼𝗶𝗻𝗶𝗻𝗴 𝗮𝗻 𝗲𝘅𝗽𝗲𝗿𝘁 𝗽𝗮𝗻𝗲𝗹 in the upcoming webinar, "Treating Blindness with Stem Cell Therapies," hosted by BioLamina. Why Attend? • Discover ground-breaking advancements in PSC-driven therapies for eye diseases. • Gain valuable industry insights. • Explore the future potential of stem cell technologies in vision care. 𝗗𝗼𝗻'𝘁 𝗺𝗶𝘀𝘀 𝘁𝗵𝗶𝘀 𝗼𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝘆 𝘁𝗼 𝗹𝗲𝗮𝗿𝗻 𝗳𝗿𝗼𝗺 𝗹𝗲𝗮𝗱𝗶𝗻𝗴 𝗲𝘅𝗽𝗲𝗿𝘁𝘀. Register for the webinar here: https://lnkd.in/eWVe3vd4 Be part of the conversation shaping the future of ocular health! #Biotechnology #CellTherapy #RegenerativeMedicine